Evidence map›Paper›PMID 38461262›Full record

SynthesisLipids in health and disease2024

Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis.

Tingting Mei, Xiaojie Huang, Shan Tang, Menglu Liu, Wenyan Zhang, Haibin Yu

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Lipids in health and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tingting MeiInterventional Therapy Center for Oncology Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Xiaojie HuangCenter for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Shan TangDepartment of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Menglu LiuState Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Wenyan ZhangState Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Haibin YuState Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. dryuhaibin@ccmu.edu.cn.
Capital Medical University · CNBeijing YouAn Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDirect-acting Antiviral Agents (DAAs) influence serum lipids of patients with Hepatitis C virus (HCV). This paper presents an analysis of the relevant literature to investigate the effects of DAAs in treating hepatitis C to achieve a sustained viral response (SVR) on lipid parameters.

methodsPubMed,Web of science, Embase and Central databases were searched, with a deadline of September 2023. Studies on the effects of sustained viral response on lipid parameters after DAAs treatment for hepatitis C were selected. The required information was extracted from the included studies, and then the Stata 12.0 was used to analyze the data quantitatively.

resultsOf 32 studies, the results showed that total cholesterol (TC) levels increased from the end of treatment (WMD = 20.144, 95%CI = 3.404, 36.884,P = 0.018) to one year after treatment (WMD = 24.900, 95%CI = 13.669, 36.131, P < 0.001). From the end of treatment (WMD = 17.728, 95%CI = 4.375, 31.082, P = 0.009) to one year after treatment (WMD = 18.528, 95%CI = 7.622, 29.433, P < 0.001), the levels of low-density lipoprotein (LDL) were also increased. High-density lipoprotein (HDL) levels were elevated from 4 weeks after treatment (WMD = 6.665, 95%CI = 3.906, 9.424, P < 0.001) to 24 weeks after treatment (WMD = 3.159,95% CI = 0.176, 6.142, P = 0.038). Triglyceride (TG) levels showed no significant change after the treatment.

conclusionsHepatitis C patients who achieved SVR on DAAs showed the increase of lipid levels and the improvement of hepatic inflammation indicators AST and ALT. This may provide evidence-based medical evidence for the follow-up and monitoring of blood lipids and hyperlipidemia treatment. REGISTRATION: PROSPERO CRD42020180793.

Indexed as

Hepatitis CHepatitis C, ChronicAntiviral AgentsHepacivirusHumansLipidsAntiviral AgentsLipidsDirect-acting Antiviral agentsHepatitis CLipidMeta-analysisSustained viral response

Identifiers

PMID38461262
PMCPMC10924993
OpenAlexW4392617877

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.